Summary of findings ‐ triple therapy: VX‐152‐tezacaftor‐ivacaftor vs placebo
Quality of life: total score · adults with cystic fibrosis and with the F508del/MF genotype
The review found no eligible studies for this question.
1 finding from 1 review
- Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found